Cavadis

Cavadis is a medical diagnostics company that specializes in cardiovascular risk assessment through the analysis of specific blood-based biomarkers. The company's core technology focuses on plasma ceramides, which have been clinically proven to be highly predictive of major adverse cardiac events, including heart attacks and strokes. By identifying high-risk patients who might otherwise be missed by traditional LDL cholesterol testing, Cavadis provides clinicians with actionable data to personalize preventative care. The company's diagnostic solutions are supported by extensive clinical validation and are aimed at reducing the global burden of cardiovascular disease.